» Articles » PMID: 3182081

Inhibition of Chlamydia Trachomatis Replication in HEp-2 Cells by Human Monocyte-derived Macrophages

Overview
Journal Infect Immun
Date 1988 Dec 1
PMID 3182081
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Monocytes (M) and macrophages are important components of the immune response to foreign agents. Using an in vitro system, we studied the influence of human M and M-derived macrophages (MdM) on the replication of Chlamydia trachomatis (L2/434) in HEp-2 cells. M or MdM were added to infected cells at a ratio of 4:1, and the resultant chlamydial yield was evaluated in one-step growth experiments. Chlamydial DNA production was evaluated by dot hybridization. Both M and MdM reduced chlamydial yield and DNA production, but the reductions caused by MdM were more pronounced. Electron microscopy showed that while control HEp-2 cells at 48 h postinfection contained large inclusions in which most particles were elementary bodies, the infected HEp-2 cells exposed to MdM contained small vacuoles with abnormal reticulate bodies and very few typical elementary bodies. Separation of the MdM from the HEp-2 cells by a membrane reduced the inhibitory effect of the MdM relative to that of MdM in direct contact with the infected cells. Addition of tumor necrosis factor antibodies to C. trachomatis-infected HEp-2 cells exposed to MdM (either in direct contact or separated by a membrane from the infected cells) reduced the inhibition of chlamydial DNA production. These data suggest the possibility that MdM may modulate C. trachomatis replication in vivo.

Citing Articles

Vaginal chlamydial clearance following primary or secondary infection in mice occurs independently of TNF-α.

Kamalakaran S, Chaganty B, Gupta R, Guentzel M, Chambers J, Murthy A Front Cell Infect Microbiol. 2013; 3:11.

PMID: 23483844 PMC: 3593625. DOI: 10.3389/fcimb.2013.00011.


T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Yang X, Brunham R Can J Infect Dis. 2012; 9(2):99-108.

PMID: 22451777 PMC: 3307538. DOI: 10.1155/1998/395297.


Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis.

Dessus-Babus S, Darville T, Cuozzo F, Ferguson K, Wyrick P Infect Immun. 2002; 70(6):3234-48.

PMID: 12011019 PMC: 128021. DOI: 10.1128/IAI.70.6.3234-3248.2002.


Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs?.

Darville T, Andrews Jr C, Rank R Infect Immun. 2000; 68(9):5299-305.

PMID: 10948158 PMC: 101792. DOI: 10.1128/IAI.68.9.5299-5305.2000.


A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.

Williams D, Magee D, Bonewald L, Smith J, Bleicker C, Byrne G Infect Immun. 1990; 58(6):1572-6.

PMID: 2341167 PMC: 258678. DOI: 10.1128/iai.58.6.1572-1576.1990.


References
1.
Armstrong J, HART P . Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med. 1975; 142(1):1-16. PMC: 2189870. DOI: 10.1084/jem.142.1.1. View

2.
Mackaness G . Cellular resistance to infection. J Exp Med. 1962; 116:381-406. PMC: 2137547. DOI: 10.1084/jem.116.3.381. View

3.
Mogensen S . Role of macrophages in natural resistance to virus infections. Microbiol Rev. 1979; 43(1):1-26. PMC: 281459. DOI: 10.1128/mr.43.1.1-26.1979. View

4.
Nacy C, Meltzer M . Macrophages in resistance to rickettsial infection: macrophage activation in vitro for killing of Rickettsia tsutsugamushi. J Immunol. 1979; 123(6):2544-9. View

5.
Morahan P, Morse S, McGeorge M . Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol. 1980; 46(2):291-300. DOI: 10.1099/0022-1317-46-2-291. View